Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mylan ireland limited, Írsko - sorafenib - 44 - cytostatica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

egis pharmaceuticals plc, maďarsko - sorafenib - 44 - cytostatica

Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastické činidlá - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pharmagen cz s.r.o., Česká republika - sorafenib - 44 - cytostatica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi oncology plc. - kapecitabín - 44 - cytostatica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fair-med healthcare gmbh, nemecko - kapecitabín - 44 - cytostatica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fair-med healthcare gmbh, nemecko - kapecitabín - 44 - cytostatica

Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hydrochlorid - kolorektálne novotvary - antineoplastické činidlá - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

exeltis slovakia s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)